Multiparametric MRI-based fusion radiomics for predicting telomerase reverse transcriptase (TERT) promoter mutations and progression-free survival in glioblastoma: a multicentre study.

MLA

Zhang, Hongbo, et al. “Multiparametric MRI-Based Fusion Radiomics for Predicting Telomerase Reverse Transcriptase (TERT) Promoter Mutations and Progression-Free Survival in Glioblastoma: A Multicentre Study.” Neuroradiology, vol. 66, no. 1, Jan. 2024, pp. 81–92. EBSCOhost, https://doi.org/10.1007/s00234-023-03245-3.

APA

Zhang, H., Zhang, H., Zhang, Y., Zhou, B., Wu, L., Yang, W., Lei, Y., & Huang, B. (2024). Multiparametric MRI-based fusion radiomics for predicting telomerase reverse transcriptase (TERT) promoter mutations and progression-free survival in glioblastoma: a multicentre study. Neuroradiology, 66(1), 81–92. https://doi.org/10.1007/s00234-023-03245-3

Chicago

Zhang, Hongbo, Hanwen Zhang, Yuze Zhang, Beibei Zhou, Lei Wu, Wanqun Yang, Yi Lei, and Biao Huang. 2024. “Multiparametric MRI-Based Fusion Radiomics for Predicting Telomerase Reverse Transcriptase (TERT) Promoter Mutations and Progression-Free Survival in Glioblastoma: A Multicentre Study.” Neuroradiology 66 (1): 81–92. doi:10.1007/s00234-023-03245-3.